Image

Integrity Implant System Post Market Clinical Follow-Up Study

Integrity Implant System Post Market Clinical Follow-Up Study

Recruiting
18 years and older
All
Phase 4

Powered by AI

Overview

The study design is a prospective, multi-center, single-arm, non-randomized post market clinical follow-up study to confirm the performance, safety and clinical benefit of the Integrity Implant System when used for rotator cuff tear augmentation (with or without repair).

Description

The Study Objective is to confirm the performance, safety and clinical benefit of the Integrity Implant System when used for rotator cuff tear augmentation (with or without repair).

The clinical success will be evaluated by absence of rotator cuff re-tear. Performance and clinical benefits will be evaluated by functional outcomes measured using standard scoring systems such as the American Shoulder and Elbow Surgeons Shoulder Score (ASES), Constant-Murley Score (CMS), Patient Satisfaction, EQ-5D-5L, Single Assessment Numeric Evaluation (SANE), Visual Analogue Scale (VAS) and rotator cuff repair outcomes measured using MRI evaluation for repair integrity, quality, tendon tissue thickness and regeneration.

Safety of the Integrity Implant System will be assessed by monitoring the frequency and incidence of adverse events.

The Primary Endpoint shall confirm the Performance of the Integrity Implant System when used for rotator cuff augmentation (with or without repair). Performance will be evaluated by an adequately powered analysis of retear rates seen by MRI at 12-months after surgery.

Eligibility

  1. At least 18 years of age
  2. Able (with assistance from LAR, if necessary) to understand the informed consent

    process, including regulatory requirements such as HIPAA authorization, and document informed consent prior to completion of any study-related procedures.

  3. Able to complete all Patient Reported Outcome Measure (PROM) questionnaires.
  4. Fully understands study requirements and able to return for all required follow-up

    visits and assessments.

  5. Able to comply with all post-operative physician prescribed rehabilitation

    instructions.

  6. Index shoulder rotator cuff tendon tear surgical access may be performed using

    mini-open, single-portal arthroscopic or multi-portal arthroscopic intervention

  7. Meets all intended use and indications for use defined within the Integrity Implant

    System IFUs as applied to rotator cuff tendon tears. These include:

Index shoulder rotator cuff tendon tear needs management and protection from injury

Index shoulder has no substantial loss of tendon tissue

Index shoulder rotator cuff tendon tear footprint allows approximation of soft tissue and fixation of the Integrity Implant to tendon tissue using an Integrity Tissue Tack

Index shoulder rotator cuff tendon tear footprint allows fixation of the Integrity Implant to bone using the Integrity Bone Staple

Exclusion Criteria

The subject exclusion criteria are as follows:

  1. Medical condition that in the PI's opinion would place the subject at risk or interfere with the study
  2. Vulnerable population (prisoners, minors, pregnant women, mentally ill persons and the elderly or any person under any undue pressure from others to participate in the study)
  3. Pregnant, breastfeeding, or plans to become pregnant during the study
  4. History of poor compliance with medical treatment of any kind
  5. Deemed contraindicated for MRI by the PI
  6. Previous rotator cuff surgery (any type) on the index shoulder
  7. Current instability of the index shoulder
  8. Rotator cuff tendon tear is a Massive Cofield Classified Full-Thickness Tear (tear length >5cm)
  9. Chondromalacia of index shoulder ≥ Grade 3
  10. Fatty infiltration of the index shoulder rotator cuff muscle ≥ Grade 3
  11. Insulin dependent Type I Diabetes
  12. History of heavy smoking (≥ 1 pack per day) within last 6-months
  13. History of auto-immune or immunodeficiency disorders
  14. Currently taking immunosuppression medication for other diseases (e.g., transplants or other inflammatory diseases)
  15. Oral steroid use in the last 2-months or injectable steroid use in the last 3-months
  16. History of cognitive or mental health status that interferes with study participation
  17. Poor comprehension of English language
  18. Meets one or more of the contraindications defined within the Integrity Implant System IFUs as applied to rotator cuff tendon tears. These include:

18.1 Rotator cuff tendon tear is deemed irreparable by the PI

18.2 Rotator cuff tendon tear repair requires replacement of damaged tendon

18.3 Rotator cuff tendon tear repair requires fixation of soft tissue to adjoining soft tissue

18.4 Rotator cuff tendon tear repair requires tendon strength reinforcement

18.5 Presence of infection

18.6 Any condition which would limit the ability or willingness to restrict activities or follow directions during the healing period

18.7 Hypersensitivity to any of the Integrity Implant System components

18.8 Inadequate soft tissue support for Integrity Tissue Tack fixation

18.9 Inadequate quality of bone for Integrity Bone Staple fixation

Study details
    Rotator Cuff Tears of the Shoulder

NCT06741527

Anika Therapeutics, Inc.

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.